What is CTD?
Creatine Transporter Deficiency is an x-linked inborn error of creatine metabolism that results in an absence of creatine in the brain. This causes severe global developmental delay, mental retardation, Autistic behavior, and expressive speech deficits.
How Can I help?
Learn about CTD, get registered in the CTD patient registry, volunteer for the CTD natural history study to be conducted at the NIH, and stay up to date on potential clinical trials. Lumos Pharma, with the help of the CTD community, hopes to provide a much needed therapeutic for those afflicted with CTD.
Learn about LUM-001
LUM-001 has shown great therapeutic potential for the treatment of CTD in a validated animal model. Lumos Pharma, in collaboration with the National Institutes of Health are conducting the necessary studies in order to initiate clinical trials in human patients.